Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ADCOCK INGRAM (S. Africa) - Comparison Results

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 TORRENT PHARMA   ADCOCK INGRAM
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-23
ADCOCK INGRAM
Jun-14
TORRENT PHARMA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs1,723317-   
Low Rs1,243229-   
Sales per share (Unadj.) Rs284.294.2-  
Earnings per share (Unadj.) Rs36.8-23.7-  
Cash flow per share (Unadj.) Rs57.7-19.7-  
Dividends per share (Unadj.) Rs22.000-  
Avg Dividend yield %1.50-  
Book value per share (Unadj.) Rs183.174.0-  
Shares outstanding (eoy) m338.45168.78-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x5.22.9 180.3%   
Avg P/E ratio x40.3-11.5 -350.9%  
P/CF ratio (eoy) x25.7-13.9 -185.5%  
Price / Book Value ratio x8.13.7 219.6%  
Dividend payout %59.80-   
Avg Mkt Cap Rs m501,77946,024 1,090.2%   
No. of employees `000NA4.3 0.0%   
Total wages/salary Rs m16,7772,889 580.8%   
Avg. sales/employee Rs Th03,705.3-  
Avg. wages/employee Rs Th0672.9-  
Avg. net profit/employee Rs Th0-933.7-  
INCOME DATA
Net Sales Rs m96,20215,907 604.8%  
Other income Rs m632111 567.5%   
Total revenues Rs m96,83416,018 604.5%   
Gross profit Rs m28,240-2,757 -1,024.5%  
Depreciation Rs m7,066687 1,029.2%   
Interest Rs m3,334431 773.9%   
Profit before tax Rs m18,472-3,763 -490.9%   
Minority Interest Rs m0-10 -0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,019235 2,560.2%   
Profit after tax Rs m12,452-4,008 -310.7%  
Gross profit margin %29.4-17.3 -169.4%  
Effective tax rate %32.6-6.2 -521.5%   
Net profit margin %12.9-25.2 -51.4%  
BALANCE SHEET DATA
Current assets Rs m53,13711,650 456.1%   
Current liabilities Rs m54,4736,555 831.0%   
Net working cap to sales %-1.432.0 -4.3%  
Current ratio x1.01.8 54.9%  
Inventory Days Days15111 14.0%  
Debtors Days Days7124 6.0%  
Net fixed assets Rs m91,3906,791 1,345.8%   
Share capital Rs m1,69274 2,291.4%   
"Free" reserves Rs m60,2880-   
Net worth Rs m61,98112,485 496.4%   
Long term debt Rs m24,9624,387 568.9%   
Total assets Rs m144,68223,585 613.4%  
Interest coverage x6.5-7.7 -84.6%   
Debt to equity ratio x0.40.4 114.6%  
Sales to assets ratio x0.70.7 98.6%   
Return on assets %10.9-15.2 -71.9%  
Return on equity %20.1-32.1 -62.6%  
Return on capital %25.1-19.8 -126.6%  
Exports to sales %21.80-   
Imports to sales %00-   
Net fx Rs m17,2590-   
CASH FLOW
From Operations Rs m23,6811,358 1,744.1%  
From Investments Rs m-24,153-417 5,793.5%  
From Financial Activity Rs m7743,982 19.4%  
Net Cashflow Rs m1,1014,923 22.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.37 Rs / ZAR

Compare TORRENT PHARMA With: ACTAVIS (US)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare TORRENT PHARMA With: LAURUS LABS   FREDUN PHARMA  BHARAT PARENTALS  ISHITA DRUGS  ORCHID PHARMA  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.